Connect with us

Cannabis

Horizons ETFs to Launch World’s First U.S.-Focused Marijuana ETF

Vlad Poptamas

Published

on

Reading Time: 3 minutes

 

Horizons ETFs Management (Canada) Inc. (“Horizons ETFs“) is pleased to announce that it has filed its final prospectus to launch the Horizons US Marijuana Index ETF. Units of the exchange traded fund (“HMUS” or the “ETF“) have been conditionally approved for listing by the NEO Exchange (“NEO“) and are slated to begin trading on April 18, 2019, under the ticker symbols HMUS (Canadian dollar units) and HMUS.U (U.S. dollar units).

HMUS will be the first ETF in the world that is solely focused on providing exposure to companies with significant business activities in, or significant exposure to, the United States marijuana or hemp industries. HMUS is an index (or passively managed) ETF, which seeks to replicate, to the extent possible, the performance of the US Marijuana Companies Index (the “Underlying Index“), net of expenses.

ETF Name

Tickers

Management Fee

Horizons US Marijuana Index ETF

HMUS (Canadian dollar units)

HMUS.U (U.S. dollar units)

0.85%
(plus applicable 
sales taxes)

The ETF will make its units available on NEO in both Canadian and U.S dollars.

“While marijuana remains federally illegal for medical and recreational usage in the United States, the number of legal cultivators and distributors at the U.S. state level continues to grow. Many of these companies have chosen Canadian stock exchanges to list their stocks in order to raise capital to meet growing investor demand,” said Steve Hawkins, President and CEO of Horizons ETFs. “HMUS will be the first index ETF solution to focus solely on identifying, and investing directly in, U.S. marijuana and hemp companies. As the U.S. continues to further liberalize its marijuana regulations, we anticipate that more investors will be looking to invest in companies with significant business operations in the U.S. market and HMUS will provide a diversified and liquid way to gain that exposure in one ETF.”

The Underlying Index is designed to provide exposure to the performance of a basket of publicly-listed companies having significant business activities in, or significant exposure to, the marijuana or hemp industries in the United States. Constituent companies will primarily include those with business activities as a producer, developer, or supplier of marijuana or hemp-based products, and can also include investment companies focused on investments in the Marijuana or Hemp industries, or companies with businesses ancillary to the Marijuana or Hemp industries.

Constituents of the Underlying Index are selected from Canadian and U.S. exchanges. While some securities may be listed on major North American exchanges, the majority of the securities currently trade on North American exchanges that include but are not limited to the Canadian Securities Exchange and NEO.

The Underlying Index is market-capitalization-weighted, subject to a cap for each constituent issuer of a maximum of 10% of the net asset value of the Underlying Index at the time of any rebalance. For a security to be eligible for the Underlying Index, the issuer will generally need to have a market capitalization of greater than $75 million.

The top-20 constituents and weights of the Underlying Index as at April 15, 2019, are in the table below. Please note that the weights of the Underlying Index and the actual portfolio weights of HMUS could be different. Horizons ETFs will not invest the assets of HMUS on a discretionary basis except to the extent it may select securities of issuers in the course of employing a stratified sampling strategy to seek to closely match the investment characteristics of the Underlying Index.

CONSTITUENT NAME

TICKER

WEIGHT

CURALEAF HOLDINGS INC

CURA :CSE

12.60%

CRESCO LABS, INC

CL :CSE

11.94%

CHARLOTTE’S WEB HOLDINGS, INC

CWEB :CSE

10.96%

MEDMEN ENTERPRISES INC

MMEN :CSE

8.68%

GREEN THUMB INDUSTRIES INC

GTII :CSE

7.61%

ACREAGE HOLDINGS INC

ACRG/U :CSE

5.16%

IANTHUS CAPITAL HOLDINGS, INC

IAN :CSE

4.96%

GREEN GROWTH BRANDS INC

GGB :CSE

3.85%

TERRASCEND CORP

TER :CSE

3.76%

CANNAROYALTY CORP

OH :CSE

3.68%

HARVEST HEALTH & RECREATION INC

HARV :CSE

3.64%

FLOWER ONE HOLDINGS INC

FONE :CSE

3.32%

SLANG WORLDWIDE INC

SLNG :CSE

2.60%

CANNABIS ONE HOLDINGS INC

CBIS :CSE

1.68%

LIBERTY HEALTH SCIENCES INC

LHS :CSE

1.62%

VALENS GROWORKS CORP

VGW :CSE

1.57%

CANNABIS STRATEGIES ACQ. CORP

CSA/a: NEO

1.48%

PLANET 13 HOLDINGS INC

PLTH :CSE

1.27%

TRULIEVE CANNABIS CORP

TRUL :CSE

1.05%

SUNNIVA INC

SNN :CSE

0.99%

Only stocks that meet minimum size and liquidity thresholds are eligible for inclusion in the Underlying Index. The composition of the Underlying Index is rebalanced at least quarterly on a market-capitalization basis, and capped so that no single stock can exceed 10% of the weight of the Underlying Index when rebalanced. Further information about the Underlying Index is available at website at www.solactive.com.

“The Horizons Marijuana Life Sciences Index ETF (HMMJ) was the first Marijuana ETF listed in the world. We launched that ETF shortly before cannabis was fully legalized in Canada,” said Mr. Hawkins. “We see a lot of similarities with the regulatory environment in the U.S. to what we saw in Canada, three years ago. If the U.S. were to enact any type of federal legalization, either medical or recreational, that would immediately make the U.S. the largest federally approved cannabis market in the world. HMUS will give investors direct diversified access to this early stage sector which has the potential of future U.S. regulatory change.”

HMUS will close the initial offering of units to its designated broker after the close of business on April 17, 2019, prior to its initial listing of units on NEO on April 18, 2019.

 

SOURCE Horizons ETFs Management (Canada) Inc.

Hello!


Thank you for visiting my profile and thank you for reading my news and published press release!


There a many things that shape a man, but the carving is done by the hobbies and passions. I've pursued two main careers, professional photography and webdesign, while also keeping a passion for automobiles, technology and games. At PICANTE NEWS, I take care of news editing and press release publishing in se
veral categories and as I've mentioned, during my spare time, I am also a professional photographer with webdesign skills.

My future plans include developing more journalistic skills and start creating investigative journalism. You can find my reports and press release coverages in the following categories:


BANKING/FINANCIAL SERVICES, COMPUTER ELECTRONICS, AUTOMOTIVE, CONTRACTS, ANALYSIS, INTERNET TECHNOLOGY, BIOTECHNOLOGY, BLOCKCHAIN, ACQUISITIONS, RETAIL, and many more.



You can get in touch to discuss interviews or possible article submissions by contacting us.


Let's also connect via social media! You can find me on Facebook or visit my photo portfolio.

Advertisement
Comments

Cannabis

Ryerson’s Chang School of Continuing Education Will Offer Business of Cannabis Course in Brampton This Spring

Vlad Poptamas

Published

on

Photo source: ce-online.ryerson.ca
Reading Time: 2 minutes

 

Ryerson University’s Raymond G. Chang School of Continuing Education announced today that it will be offering its course on The Business of Cannabis (CZEN 420) in Brampton. Classes will run from May 8 to July 31 on Wednesdays, from 6:30 p.m.–9:30 p.m.

Offering this cannabis course in Brampton is a natural progression, given that the City of Brampton was one of the first Ontario cities to open a cannabis retail store earlier this month.

“The legalization of recreational cannabis has presented an exciting array of employment and business opportunities throughout the Canadian market,” said Marie Bountrogianni, Dean of The Chang School. “We look forward to bringing the Business of Cannabis to the Brampton community to help adult learners build their capacity to contribute to this dynamic and growing industry.”

Building on Ryerson’s expertise in entrepreneurship education, The Business of Cannabis explores a range of topics including financing for cannabis businesses and the complex regulations pertaining to the cultivation, processing, and distribution, marketing and selling of cannabis. Students learn how to apply entrepreneurship principles such as opportunity identification and evaluation, lean methods and bootstrapping. They will also have the opportunity to create a business plan and get in-person access to key cannabis industry leaders during planned panel discussions.

“Our programming is shaped by a diverse group of advisors who lead the way in the industry. Their expertise in business strategy and development, branding, science, health, as well as law and regulation has allowed Ryerson to offer this one-of-a-kind program. This is extremely important for an area that is complex and continues to change at a breakneck speed,” said Linda Koechli, Program Director, Business.

The Chang School of Continuing Education recognizes the societal need for education and awareness about cannabis in order to support this growing and changing industry. The objective of the course is to give Canadian entrepreneurs a competitive edge in seizing the opportunities available in what has become a billion dollar business in Canada. The course will increase employability for those seeking entry- or intermediate-level functional positions in the cannabis industry.

The Business of Cannabis is just one of many innovative and forward-thinking courses offered by The Chang School in Brampton. The institution has been offering courses on cybersecurity since January 2019. For spring, The Chang School will once again be offering courses in in this timely subject area: Digital Forensics Systems (CKDF 130) and Continuity and Risk Management (CSCI 243) will be available to help meet the demand for skills needed in the field.

Visit this website for more information about The Chang School’s The Business of Cannabis course.

Ryerson University’s G. Raymond Chang School of Continuing Education is Canada’s foremost provider of university-based adult education, facilitating access to the university’s renowned, professionally relevant courses and programs. Our mission is to provide accessible lifelong learning through innovative programming that empowers adults to reach their life and career goals. We offer 81 certificate programs (31 of which can be completed entirely online), 12 part-time degree programs, and 65 course series. Our Experiential Learning Exchange (ELX) offers self-driven instruction that emphasizes hands-on, project-based learning and connects students with experienced industry leaders through coaching, master classes, and professional networking.

SOURCE Ryerson University

Continue Reading

Cannabis

Aphria Secures Cannabis Cultivation License in Germany

Vlad Poptamas

Published

on

Photo source: massroots.com
Reading Time: 1 minute

 

Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA and NYSE: APHA) today announced that its German subsidiary Aphria Deutschland GmbH (“Aphria Germany“) has secured the previously announced license for the domestic cultivation of medical cannabis from the German Federal Institute for Drugs and Medical Devices (“BfArM“), following the conclusion of a mandatory 10-day standstill period for public contracts. Aphria was granted a cultivation license for four of the nine total lots awarded by BfArM and is awaiting the completion of the tender process for the four remaining lots under review, one of which was provisionally awarded to Aphria Germany.

“Aphria thanks the BfArM for their diligent examination and validation of our approach for domestic cultivation with this license,” said Hendrik Knopp, Managing Director of Aphria Germany. “Construction on our 8,000 square meter indoor cultivation facility is already underway and we anticipate it will be fully operational by Summer 2020. We are pleased to additionally support German patients in the upcoming months with high-quality imported cannabis flower and oils from Denmark and Canada.”

Aphria Germany is building its indoor growing facility in Neumünster and is completing work on a state-of-the-art GMP-certified cannabis vault in Bad Bramstedt for the import of cannabis flowers and oil from Canada and Denmark. Aphria Germany also holds a 25.1% interest in Berlin-based Schöneberg Hospital, which provides access to both doctors and patients for education on the benefits of medical cannabinoids. Earlier this month, the company launched CannRelief, a CBD-based nutraceutical and cosmetics product line for the German market, produced in the EU and distributed by CC Pharma, a subsidiary of Aphria Inc. with access to more than 13,000 pharmacies throughout Germany.

We Have A Good Thing Growing

 

SOURCE Aphria Inc.

Continue Reading

Cannabis

Introducing Lab Effects, The Sleeping Giant Of The Cannabis Terpene Industry

Vlad Poptamas

Published

on

Photo source: pinterest.co.uk
Reading Time: 2 minutes

 

Since 2012, Lab Effects, the cannabis industry’s longest running terpene laboratory, has been working behind the scenes engineering products for many of the industries well-known brands. Many of whom have stayed quiet for fear of revealing the secret source behind their award-winning products. Today, for the first time in seven years, the company has stepped out from behind the curtain and announced the launch of its new website http://www.labeffects.com.

“Previously only companies who knew us through word of mouth could access the breadth of our offerings,” said Scott Holden, CEO, and Founder of Lab Effects. “Our new website culminates years of terpene science advancement. Now everyone has access to our terpene blends in a wide variety of formats that satisfy virtually any application a manufacturer could conceive.”

Until recently, product manufacturers were limited in how they could manipulate terpenes. Lab Effects has achieved the ability to render any terpene profile into formats such as water-soluble liquids, powders, and static free high speed flowable and compressible powders. Now, the sky is the limit when it comes to formulations of any kind: food, beverage, pharmaceutical, topical, and much more.

“Lab Effects presents the ability for any manufacturer to achieve a much broader formulation goal that would not have been technically feasible by utilizing terpenes in their natural state,” Holden said. “Lab Effects offers a toolkit for product manufacturers who want to leverage the power of terpenes, which are now being widely recognized as one of the secrets behind the most efficacious cannabis formulations.”

Consider the hops used in making beer. Humulene, a terpene found in hops, influences the flavor and aroma of beer…and that’s just one isolated terpene. Imagine what you can do with hundreds of isolated and blended terpenes. Picture a menu of beers with cannabis profile terpenes: Chocolate Thai Porter, Tangerine Haze Wheat, Durban Poison IPA. You get the flavor, aroma, and effects of each coveted terpene blend (without the THC).

According to Lab Effects, the floodgates have opened for product innovation in the cannabis industry and beyond. Browse their extensive collection of pure terpenes (both cannabis-derived and botanical) at www.labeffects.com.

 

SOURCE Lab Effects

Continue Reading

Font Resizer

Subscribe to PICANTE via Email

Enter your email address to subscribe to PICANTE and receive notifications of new posts by email.

Follow us on Facebook

Read more from our authors

Follow our Tweets

Trending

Please turn AdBlock off